| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b72691b61448140b9a080282c2ccf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2df259e348a79b51158d007a0a721a03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d98b234f77f65992ce19359dda302ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13431d81049b9bd19951399c741a5065 |
| publicationDate |
2021-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210148772-A |
| titleOfInvention |
Use of TCOF1 for the diagnosis or prognosis of colorectal cancer patients |
| abstract |
The present invention relates to the use of TCOF1 for diagnosis or prognosis of colorectal cancer patients. Specifically, TCOF1 is a protein that binds to β-catenin in colorectal cancer cell lines. As the expression of TCOF1 increases, β -Catenin (β-catenin) activity increases, TCOF1 protein binds to β-catenin (β-catenin) and increases the stability of β-catenin (β-catenin) accumulation of β-catenin , the combined TCOF1 protein of TCOF1 protein and β-catenin provides a biomarker for diagnosis or prognosis of colorectal cancer, and the expression level of TCOF1 protein or TCOF1 protein and β-catenin (β -catenin) By measuring the binding level, it provides a method of providing information for diagnosing or prognosing colorectal cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116144669-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116144669-A |
| priorityDate |
2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |